Radiomics Facilitates Candidate Selection for Irradiation Stents Among Patients With Unresectable Pancreatic Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00973
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Systematic Review of FOLFIRINOX in Patients With Locally Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Outcomes With FOLFIRINOX for Borderline Resectable and Locally Unresectable Pancreatic Cancer

Journal of Surgical Oncology
MedicineSurgeryOncology
2013English

Intra-Arterial and Tumor-Targeted Infusion of Gemcitabine in Patients With Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

SBRT for Unresectable Pancreatic Cancer Can Improve Local Control With Minimal Toxicity

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Overall Mortality and Pancreatic Cancer Mortality Among Patients With Pancreatic Cystic Neoplasms

Gastroenterology
HepatologyGastroenterology
2018English

Impact of the Treatment of Pancreatic Exocrine Insufficiency on Survival of Patients With Unresectable Pancreatic Cancer: A Retrospective Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Pyloric Ligation: A Novel Approach to Reduce Delayed Gastric Emptying in Patients With Unresectable Pancreatic Cancer

Journal of the American College of Surgeons
Surgery
2017English

Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy